Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ($)

Teva Pharmaceuticals revenue was $16.66 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$22.39 b$18.85 b$16.89 b$16.66 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$5.07 b$4.7 b$4.53 b$4.3 b$4.34 b$4.26 b$4.36 b$3.87 b$3.98 b

Annual Growth Rate (%)

Revenue Breakdown

Geographic Segment

Teva Pharmaceuticals revenue breakdown by geographic segment: 54.8% from North America, 30.8% from Europe and 14.4% from International Markets

FY, 2017
Generic Medicines$12.26 b
Specialty Medicines$7.91 b
Other$2.21 b
FY, 2019FY, 2018FY, 2017
United States (Generic Medicines)$5.04 b
Europe (Generic Medicines)$3.99 b
Rest of the World (Generic Medicines)$3.23 b
United States (Specialty Medicines)$5.69 b
Europe (Specialty Medicines)$1.78 b
Rest of the World (Specialty Medicines)$448 m
United States (Other)$1.25 b
Europe (Other)$308 m
Rest of the World (Other)$655 m
North America$8.54 b$9.3 b
Europe$4.8 b$5.19 b
International Markets$2.25 b$3.01 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu